Financial impact of a novel pre-eclampsia diagnostic test versus standard practice: a decision-analytic modeling analysis from a UK healthcare payer perspective

References

• Stella CL, Sibai BM. Preeclampsia: Diagnosis and management of the atypical presentation. J Matern Fetal Neonatal Med 2006;19:381-6
   PubMed Web of Science ®Google Scholar
• Wagner LK. Diagnosis and management of preeclampsia. Am Fam Physician 2004;70:2317-24
   PubMed Web of Science ®Google Scholar
• Milne F, Redman C, Walker J, et al. The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community. BMJ 2005;330:576-80
   PubMed Web of Science ®Google Scholar
• Bhattacharya S, Campbell DM. The incidence of severe complications of preeclampsia. Hypertens Pregnancy 2005;24:181-90
   PubMed Web of Science ®Google Scholar
• Buhimschi CS, Norwitz ER, Funai E, et al. Urinary angiogenic factors cluster hypertensive disorders and identify women with severe preeclampsia. Am J Obstet Gynecol 2005;192:734-41
   PubMed Web of Science ®Google Scholar
• Muy-Rivera M, Vadachkoria S, Woelk GB, et al. Maternal plasma VEGF, sVEGF-R1, and PlGF concentrations in preeclamptic and normotensive pregnant Zimbabwean women. Physiol Res 2005;54:611-22
   PubMed Web of Science ®Google Scholar
• Woolcock J, Hennessy A, Xu B, et al. Soluble Flt-1 as a diagnostic marker of pre-eclampsia. Aust N Z J Obstet Gynaecol 2008;48:64-70
   Google Scholar
• Robinson CJ, Johnson DD, Chang EY, et al. Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia. Am J Obstet Gynecol 2006;195:255-9
   PubMed Web of Science ®Google Scholar
• Lee ES, Oh MJ, Jung JW, et al. The levels of circulating vascular endothelial growth factor and soluble Flt-1 in pregnancies complicated by preeclampsia. J Korean Med Sci 2007;22:94-8
   PubMed Web of Science ®Google Scholar
• Kim YJ, Park H, Lee HY, et al. Paraoxonase gene polymorphism, serum lipid, and oxidized low-density lipoprotein in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2007;133:47-52
   PubMed Web of Science ®Google Scholar
• Teixeira PG, Cabral AC, Andrade SP, et al. Placental growth factor (PlGF) is a surrogate marker in preeclamptic hypertension. Hypertens Pregnancy 2008;27:65-73
   PubMed Web of Science ®Google Scholar
• Noori M, Donald AE, Angelakopoulou A, et al. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension. Circulation 2010;122:478-87
   PubMed Web of Science ®Google Scholar
• Verlohren S, Galindo A, Schlembach D, et al. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol 2010;202:161.e1-161.e11 (Epub 2009 Oct 21)
   PubMed Web of Science ®Google Scholar
• Meads CA, Cnossen JS, Meher S, et al. Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess 2008;12:1-270
   Web of Science ®Google Scholar
• British National Formulary (BNF). (Accessed July 2009). Available online at https://www.medicinescomplete.com/mc/bnf/current/login.htm
   Google Scholar
• National Health Service (NHS). (Accessed July 2009). Payment by Results: Guidance and Tariff for 2008-09. Available online at http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_081096
   Google Scholar
• Mulhaven Medical Laboratory. (Accessed July 2009). Laboratory Testing Prices. Available at http://www.mullhaven.co.uk/index1.htm
   Google Scholar
• Murphy DJ, Stirrat GM. Mortality and morbidity associated with early-onset preeclampsia. Hypertens Pregnancy 2000;19:221-31
   PubMed Web of Science ®Google Scholar
• Lapaire O, Shennan A, Stepan H. The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application. Eur J Obstet Gynecol 2010;151:122-9
   PubMed Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672-83
   PubMed Web of Science ®Google Scholar
• Cnossen JS, ter Riet G, Mol BW, et al. Are tests for predicting pre-eclampsia good enough to make screening viable? A review of reviews and critical appraisal. Acta Obstet Gynecol Scand 2009;88:758-65
   PubMed Web of Science ®Google Scholar
• UK Office for National Statistics. (Accessed August 2009). Key Population and Vital Statistics, Series VS No 34, PPI No 30, 2007 data, corrected version issued on 27 April 2009. Available online at http://www.statistics.gov.uk/downloads/theme_population/KPVS34-2007/KPVS2007.pdf
   Google Scholar
• Bellamy L, Casas JP, Hingorani AD, et al. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007;335:974. Epub 2007 Nov 1
   PubMed Web of Science ®Google Scholar
• McDonald SD, Malinowski A, Zhou Q, et al. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J 2008;156:918-30
   PubMed Web of Science ®Google Scholar
• Funai EF, Friedlander Y, Paltiel O, et al. Long-term mortality after preeclampsia. Epidemiology 2005;16:206-15
   PubMed Web of Science ®Google Scholar
• Sibai BM. Caring for women with hypertension in pregnancy. JAMA 2007;298:1566-8
   PubMed Web of Science ®Google Scholar
• National Institute for Clinical Excellence, Scottish Executive Health Department, Department of Health, Social Services and Public Safety, Northern Ireland. Saving mothers's lives;2003–2005. The seventh report of the confidential enquiries into maternal deaths in the United Kingdom. London: CEMACH, 2007
   Google Scholar